Market Insight : Venous Thromboembolism Therapeutics Market Globally Grow at a CAGR of 6.40% by Revenue During the Forecast Period 2017-2021

ResearchMoz presents professional and in-depth study of “Global Venous Thromboembolism Therapeutics Market 2017-2021”.

The global VTE therapeutics market is expected to benefit from the growing incidence of VTE worldwide. According to the CDC, every year around 0.9 million individuals are affected by VTE in the US and 60,000 to 100,000 individuals in the US die of VTE. Further, the presence of high unmet medical needs is expected to fuel the market growth. For instance, according to the CDC approximately 50% of individuals with VTE will have long-term complications, and 33% of individuals will have a recurrence within ten years.

Technavios analysts forecast the global venous thromboembolism therapeutic market to grow at a CAGR of 6.40% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global venous thromboembolism therapeutic market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of VTE products in the following drug classes.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Get PDF for more Professional and Technical insights @ http://www.researchmoz.us/enquiry.php?type=S&repid=1027808

Technavio’s report, Global Venous Thromboembolism Therapeutic Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Bayer HealthCare
BMS
Boehringer Ingelheim
Daiichi Sankyo
Johnson & Johnson
Sanofi

Other prominent vendors
Altor Bioscience
Armetheon
Aspen Pharma
BioInvent International
eXIthera Pharmaceuticals
Gamma Therapeutics
GlycoMimetics
Green Cross
Isis Pharmaceutical
Leo Pharma
Pfizer
Portola Pharmaceuticals
ThromboGenics

Market driver
Increasing surgical procedures such as hip and knee replacements.
For a full, detailed list, view our report

Market challenge
Presence of alternatives such as thrombectomy and percutaneous techniques.
For a full, detailed list, view our report

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=1027808

Market trend
Development of drugs for new indications.
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States – 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on Blogger at: http://latestmedicalrelatedresearchreport.blogspot.in/

%d bloggers like this: